Table 1.
Participant characteristics and anthropometric measurements from adult males with (DMD and BMD) and without (Control) muscular dystrophy (MD).
| Control | DMD | BMD | |
|---|---|---|---|
| N | 12 | 15 | 13 |
| Ambulatory | 12 | 0 | 4 |
| Current corticosteroid use (n) | 0 | 6 | 0 |
| Age (Years) | 27.1 ± 7.4 | 24.6 ± 4.3 | 43.7 ± 7.3 *,# |
| Height (m) | 1.80 ± 0.08 | 1.68 ± 0.07 *,# | 1.76 ± 0.07 |
| Body Mass (Kg) | 79.7 ± 11.9 | 71.5 ± 13.8 | 96.5 ± 20.6 *,# |
| BMI (Kg/m2) | 24.6 ± 2.5 | 25.2 ± 4.1 | 31.1 ± 6.7 *,# |
| Fat Mass (Kg) | 13.9 ± 6.4 | 22.6 ± 6.2 * | 36.9 ± 17.6 *,# |
| Body Fat% | 16.4 ± 5.5 | 31.3 ± 3.8 * | 35.4 ± 8.2 * |
| FFM (Kg) | 65.7 ± 7.4 | 48.9 ± 8.6 *,# | 59.5 ± 13.4 |
| Relative FFM (%) | 83.1 ± 5.5 | 68.7 ± 3.8 * | 62.9 ± 12.7 * |
| VL ACSA (cm2) | 32.2 ± 8.6 | 16.3 ± 9.5 * | 16.9 ± 6.9 * |
| n with IGT | 0 | 8 | 6 |
| PASIPD | - | 7.2 ± 7.1 | 12.9 ± 7.8 |
| BPAQ | 49.7 ± 48.0 | 5.9 ± 8.2 * | 10.1 ± 10.2 * |
Data are presented as mean ± SD. BMI, body mass index; FFM, fat free mass; VL ACSA, vastus lateralis anatomical cross sectional area; IGT, impaired glucose tolerance; PASIPD, Physical Activity Score for Individuals with Physical Disabilities; BPAQ, bone specific physical activity score. PASIPD scores are omitted for the control group, as the questionnaire is specific for persons with disability. * denotes a significant difference from control (p < 0.05). # denotes a significant difference between Becker muscular dystrophy (BMD) and Duchenne muscular dystrophy (DMD) (p < 0.05).